Literature DB >> 32417934

Recent updates and developments in PET imaging of prostate cancer.

Steven P Rowe1,2, Geoffrey B Johnson3, Martin G Pomper4,5, Michael A Gorin4,5, Spencer C Behr6.   

Abstract

A number of positron emission tomography (PET) radiotracers have been developed to improve the sensitivity and specificity of imaging for prostate cancer. These radiotracers include the bone-seeking agent Na18F as well as more tumor-specific compounds such as 11C-choline and 18F-fluciclovine. In this review, we will discuss the advantages and disadvantages of these PET radiotracers for the imaging of men with prostate cancer across a range of clinical contexts. We will also touch upon radiotracers in late clinical development that have not gained regulatory approval, including those targeted against prostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptor (GRPR).

Entities:  

Keywords:  Axumin; Bombesin; Choline; Fluciclovine; GRPR; PSMA

Mesh：

Substances：

Year:  2020        PMID： 32417934     DOI： 10.1007/s00261-020-02570-y

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  58 in total

1.  Fluorine-18: a new isotope for bone scanning.

Authors:  M BLAU; W NAGLER; M A BENDER
Journal:  J Nucl Med       Date:  1962-07       Impact factor: 10.057

2.  Diagnostic test accuracy study of 18F-sodium fluoride PET/CT, 99mTc-labelled diphosphonate SPECT/CT, and planar bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer.

Authors:  Randi F Fonager; Helle D Zacho; Niels C Langkilde; Joan Fledelius; June A Ejlersen; Christian Haarmark; Helle W Hendel; Mine Benedicte Lange; Mads R Jochumsen; Jesper C Mortensen; Lars J Petersen
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-11-01

3.  The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.

Authors:  Einat Even-Sapir; Ur Metser; Eyal Mishani; Gennady Lievshitz; Hedva Lerman; Ilan Leibovitch
Journal:  J Nucl Med       Date:  2006-02       Impact factor: 10.057

Review 4.  Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations.

Authors:  Hossein Jadvar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-22       Impact factor: 9.236

5.  Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer.

Authors:  Steven P Rowe; Katarzyna J Macura; Anthony Ciarallo; Esther Mena; Amanda Blackford; Rosa Nadal; Emmanuel S Antonarakis; Mario A Eisenberger; Michael A Carducci; Ashley E Ross; Philip W Kantoff; Daniel P Holt; Robert F Dannals; Ronnie C Mease; Martin G Pomper; Steve Y Cho
Journal:  J Nucl Med       Date:  2015-10-22       Impact factor: 10.057

6.  Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.

Authors:  R L Wahl; L E Quint; R L Greenough; C R Meyer; R I White; M B Orringer
Journal:  Radiology       Date:  1994-05       Impact factor: 11.105

7.  PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?

Authors:  Steven P Rowe; Margarita Mana-Ay; Mehrbod S Javadi; Zsolt Szabo; Jeffrey P Leal; Martin G Pomper; Kenneth J Pienta; Ashley E Ross; Michael A Gorin
Journal:  Clin Genitourin Cancer       Date:  2015-09-30       Impact factor: 2.872

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Treatment Response Assessment of Skeletal Metastases in Prostate Cancer with 18F-NaF PET/CT.

Authors:  Erik M Velez; Bhushan Desai; Hossein Jadvar
Journal:  Nucl Med Mol Imaging       Date:  2019-06-24

10.  Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT.

Authors:  Kalevi Kairemo; Timo Joensuu
Journal:  Diagnostics (Basel)       Date:  2015-10-13
View more
  1 in total

Review 1.  Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy.

Authors:  Terry W Moody; Lingaku Lee; Irene Ramos-Alvarez; Tatiana Iordanskaia; Samuel A Mantey; Robert T Jensen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.